were conducted to determine the in vivo effect of acetaminophen (AAP) on the lipid peroxidation, drug metabolizing enzyme activity and microsomal electron transfer system of rat and mouse liver. AAP was found to inhibit ethyl morphine N-demethylase activity in the presence of NADPH and this inhibition of the enzyme was due to decrease in cytochrome P-450 content, but not due to change in lipid peroxidation in liver microsomes. Kinetical data showed that AAP administration had no effect on Km values of ethylmorphine N-demethylase, however, a decrease in the Vmax values was seen in rats and mice. There was no significant effect of AAP on both NADPH-cytochrome c reductase and the content of cytochrome b5 3 hours after this administration to rats and mice. On the other hand, AAP induced a signifi cant decrease in NADH-ferricyanide reductase in mice, but not in rats. The greatest decrease in cytochrome P-450 was observed among the components of the liver micro somal electron transfer system of rats and mice.
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Acetaminophen (AAP) is widely used as an analgesic, and its covalent binding to macromolecules has been reported when a large oral dose only of AAP was given (1, 2) , and such may be attributed to production of hepatic necrosis in man (3). The drug is, however, remarkably safe in therapeutic doses (4).
AAP is known to be metabolized by enzymes in liver microsomes and produces an active metabolite, N-hydroxy-acetaminophen (5, 6) . Studies in experimental animals have shown that when higher doses are given, a reactive metabolite of the drug binds covalently with liver cell protein (5, 7, 8) . Thorgeirsson et al. (9) demonstrated that changes in bio chemical parameters were noted in both male mice and male hamsters after AAP admin istration.
Previous studies in this laboratory demonstrated that AAP has characteristics of type II substrate for microsomal mixed function oxygenase and inhibits ethylmorphine N demethylation in the noncompetitive type and aniline hydroxylation in the competitive one, respectively (10) . It has been reported that mice were susceptible to the hepatotoxic effects of AAP, while rats were resistant to the AAP poisoning (2) .
The purpose of the present study was to investigate the comparison of the in vivo effects of AAP on drug metabolizing enzymes and lipid peroxidation in liver microsomes of rats and mice.
MATERIALS AND METHODS

Enzyme preparation
Male Wistar rats weighing 150-180 g and male ddy mice weighing about 20 g were used throughout. Following deprivation of all food, livers were removed and perfused with 1.15% KCl to remove the blood. These tissues were homogenized in 3 volumes of ice-cold 1.15 % KC1 in a Potter-Elvehjem type homogenizer with a Teflon pestle, and the homogenate was centrifuged at 9,000 g for 20 min. After recentrifugation of the supernatant of 10,5000 g for 1 hr, the microsomal pellet was resuspended in 1.15 % KCI to contain about 2 mg protein per ml.
Enzyme assay
Ethylmorphine N-demethylase activity was measured by determination of formaldehyde formed according to the method of Nash (11) . NADH-ferricyanide reductase and NADPH-cytochrome c reductase activities were assayed by the methods of Takesue and
Omura (12) and Omura and Takesue (13), respectively.
Analytical methods
Cytochrome b5 content was determined by the method of Omura and Takesue (13) .
Cytochrome P-450 content was determined from CO difference spectra of the dithionite treated sample as described by Omura and Sato (14) . Lipid peroxidation was measured by the method of Zalkin and Tappel (15) .
Protein determination
The microsomal protein was determined according to the method of Lowry et al. (16) .
Statistical analysis of data was performed using Student's t-test.
RESULTS
Effect of acetaminophen on ethylmorphine N-demethylase activity of liver microsomes in rats and mice As shown in Table 1 , a single administration of AAP (500 mg/kg, i.p.) to rats produced no significant change in ethylmorphine N-demethylase activity. However, treatment of rats with AAP for two successive days produced a decrease in the enzyme activity to about 60 % that seen in control animals, when the incubation was conducted in the presence of EDTA, for the assay of the enzyme activity. EDTA is known to be an inhibitor of lipid peroxidation and stabilizes the activity of the drug metabolizing enzymes in liver microsomes (17) . Ethylmorphine N-demethylase activity in mice after a single administration of AAP was significantly decreased in both the presence and absence of EDTA.
On the other hand, decrease in ethylmorphine N-demethylase of AAP-treated animals and controls occurred to the same extent in the presence and absence of EDTA. Therefore, it is likely that lipid peroxidation was not involved in the inhibition of ethylmorphine N demethylase by AAP administration to rats and mice.
Effect of acetanunophen on the microsomal lipid peroxidation in rats and mice Table 2 shows that no significant changes in lipid peroxidation occurred with liver microsomes from rats and mice after AAP administration.
This phenomenon supports the finding shown in Table 1 , that is, the ratios of the value with added EDTA to that without added EDTA were not affected by AAP administration. figure) , and AAP-treated rats ( -) and controls (-s-) (C and D on the figure) were calculated from Lineweaver-Burk plots. Experimental details on the incubation mixture were as described in Table 1 except that incubation was carried out at 37 C for 20 min.
Effect of acetaminophen treatment on Km valises for ethylmorphine N-demethylation ill rats atld Mice 1il vitro studies in our laboratory demonstrated that AAP was found to be a noncompe titive inhibitor for ethylmorphine N-demethylase. In the present study, ill vivo effect of AAP on ethylmorphine N-demethylase activity was investigated. Fig. I shows a reciprocal plot of the mixed function oxygenase-dependent inhibition of ethylmorphine N-demethylation after :SAP administration to rats and mice. As determined from a Lineweaver-Burk plot (18) , Km values for control and AAP treated liver microsomes (mouse) were almost identical in the presence (0.83 mM) and absence (1.11 mM) of EDTA (0.1 mM) (Fig. 1A and 1B) .
Kni values for rat liver microsomes were 0.25 mM in the presence of EDTA and 0.87 mM in the absence of the chemical (Fig. 1C and 1D ).
ChatTes ill iicrosomal electron transfer system after acetaminophen adlniillstratioil to rats awl mice
To assess the functional state of liver microsomal drug metabolizing enzymes utilizing cytochrome P-450 as the terminal oxidase, an enzymatic reaction known to require cytochrome P-450 or to participate in the microsomal electron transfer system was measured.
As shown in Table 3 , AAP did not alter the specific activity of NADPH-cytochrome c reductase in both species after AAP treatment. The activity of NADH-ferricyanide reductase was slightly decreased, but such was not statistically significant, after AAP administration to rats. The enzyme activity in mice decreased to a greater degree (P<0.05) than that in rats. Table 3 also shows that AAP treatment produced a decrease in the amount of cyto chrome P-450 in rats and mice, but there was no change in the amount of cytochrome b; r per mg of microsomal protein after AAP administration to rats and mice. 
DISCUSSION
Our results herein show that there was no change in ethylmorphine N-demethylase activity in rats 3 hr after a single administration of AAP (500 mg/kg, i.p.), while significant decrease in the enzyme activity occurred in mice even after a single administration of the drug.
The decrease in ethylmorphine N-demethylase activity in AAP-treated mice and rats was not due to activation of liver microsomal lipid peroxidation, but to a significant depletion in the cytochrome P-450 content (Table 3 ). Kinetical data showed that administration of AAP to both rats and mice did not alter the Km values for ethylmorphine N-demethylase, however, Vmax values decreased in both species.
Since the activity of lipid peroxidation was greater in rats than in mice, the effect of EDTA on Km values for ethylmorphine N-demethylase was necessarily greater in rats than in mice. These findings were in accordance with our previous report (17) .
The present work also demonstrated that AAP has no significant effect on the reductase activities associated with the microsomal electron transfer system, although the activity of NADH-ferricyanide reductase in mice was decreased. In contrast, cytochrome P-450 content was markedly decreased by AAP administration. Thorgeirsson et al. (9) demon strated that incorporation of 3H-leucine into liver protein decreased even 3 hr after the administration of AAP, although this inhibition of protein synthesis may be the result of decrease in cytochrome P-450. The other components of drug metabolyzing enzyme systems were not altered significantly except for the significant decrease in NADH ferricyanide reductase in mice. Accordingly, this degradation of cytochrome P-450 was, mediated through other mechanisms as described below.
Preliminary experiments in this laboratory have demonstrated that the in vitro addition
of N-hydroxyaniline, analog of N-hydroxy-acetaminophen, to the cuvette containing liver microsomes caused a significant decrease in cytochrome P-450 CO-difference spectrum without appearance of cytochrome P-420. Moreover, addition of reduced glutathione prior to the addition of N-hydroxyaniline to the cuvette effectively blocked decrease in levels of cytochrome P-450 (data not shown).
From these results it can be speculated that liver cytochrome P-450 may be more suscep tible to AAP metabolites than other constituents of the microsomal electron transfer system.
Finally, AAP is metabolized to an active metabolite, N-hydroxy-acetaminophen through liver microsomal drug metabolizing enzymes, and the labile metabolite formed from AAP by cytochrome P-450 reacts initially with cytochrome P-450 itself unless there is no scavenger(s) for the active metabolite existing in the microsomes. Therefore, severe de struction of liver function may be due to the active metabolite of AAP, but not to increase in lipid peroxidation.
